98
Views
0
CrossRef citations to date
0
Altmetric
Review

Practical diagnostic algorithms for Chagas disease: a focus on low resource settings

ORCID Icon, , ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 1287-1299 | Received 08 Aug 2023, Accepted 31 Oct 2023, Published online: 18 Nov 2023

References

  • Pérez-Molina JA, Molina I. Chagas Disease. Lancet. 2018;391:82–94. doi: 10.1016/S0140-6736(17)31612-4
  • PAHO Factsheet: Chagas disease in the Americas for public Health workers. [cited 2023 Jul 20]. Available from: https://www.paho.org/en/documents/factsheet-chagas-disease-americas-public-health-workers
  • Picado A, Cruz I, Redard-Jacot M, et al. The burden of congenital Chagas disease and implementation of molecular diagnostic tools in Latin America. BMJ Glob Health. 2018;3:1069. doi: 10.1136/bmjgh-2018-001069
  • Schijman AG, Alonso-Padilla J, Longhi SA, et al. Parasitological, serological and molecular diagnosis of acute and chronic Chagas disease: from Field to laboratory. Mem Inst Oswaldo Cruz. 2022;117. doi: 10.1590/0074-02760200444
  • PAHO. Guidelines for the Diagnosis and Treatment of Chagas Disease; (WA) DC: Pan-American Health Organization. 2019 [cited 2023 Jul 20]. Available from: https://iris.paho.org/bitstream/handle/10665.2/49653/9789275120439_eng.pdf
  • Feilij H, Muller L, Cappa G. Direct micromethod for diagnosis of acute and congenital Chagas’ disease. J Clin Microbiol. 1983;18:327. doi: 10.1128/JCM.18.2.327-330.1983
  • De Castro AM, Luquetti AO, Rassi A, et al. Detection of parasitemia profiles by blood culture after treatment of human chronic Trypanosoma cruzi infection. Parasitol Res. 2006;99:379–383. doi: 10.1007/s00436-006-0172-5
  • Stevens L, Dorn PL, Schmidt JO, et al. Kissing bugs. The Vectors of Chagas. Adv Parasitol. 2011;75. doi: 10.1016/B978-0-12-385863-4.00008-3
  • Besuschio SA, Llano Murcia M, Benatar AF, et al. Analytical sensitivity and specificity of a loop-mediated isothermal amplification (LAMP) kit prototype for detection of Trypanosoma cruzi DNA in human blood samples. PLoS Negl Trop Dis. 2017;11:e0005779. doi: 10.1371/JOURNAL.PNTD.0005779
  • Mondal D, Ghosh P, Khan MAA, et al. Mobile suitcase laboratory for Rapid detection of Leishmania donovani using recombinase polymerase amplification assay. Parasites Vectors. 2016;9:1–8. doi: 10.1186/s13071-016-1572-8
  • Suescún-Carrero SH, Tadger P, Cuellar CS, et al. Rapid diagnostic tests and ELISA for diagnosing chronic Chagas disease: systematic revision and meta-analysis. PLoS Negl Trop Dis. 2022;16:e0010860. doi: 10.1371/JOURNAL.PNTD.0010860
  • Egüez KE, Alonso-Padilla J, Terán C, et al. Rapid Diagnostic Tests Duo as Alternative to Conventional Serological Assays for Conclusive Chagas Disease Diagnosis. PLoS Negl Trop Dis. 2017;11(4):e0005501. doi: 10.1371/JOURNAL.PNTD.0005501
  • Lozano D, Rojas L, Méndez S, et al. Use of Rapid diagnostic tests (RDTs) for conclusive diagnosis of chronic Chagas disease – Field implementation in the Bolivian Chaco region. PLoS Negl Trop Dis. 2019;13:e0007877. doi: 10.1371/JOURNAL.PNTD.0007877
  • Lopez-Albizu C, Danesi E, Piorno P, et al. Rapid diagnostic tests for Trypanosoma cruzi infection: field Evaluation of two registered kits in a region of endemicity and a region of nonendemicity in Argentina. J Clin Microbiol. 2020;58. doi: 10.1128/JCM.01140-20
  • Mendicino D, Colussi C, Moretti E. Simultaneous use of two Rapid diagnostic tests for the diagnosis of Chagas disease. Trop Doct. 2019;49(1):23–26. doi: 10.1177/0049475518813792
  • Suescún-Carrero SH, Salamanca-Cardozo LP, Pinazo MJ, et al. Sensitivity and specificity of two Rapid tests for the diagnosis of infection by Trypanosoma cruzi in a Colombian population. PLoS Negl Trop Dis. 2021;15(6):e0009483. doi: 10.1371/JOURNAL.PNTD.0009483
  • Pinazo MJ, Gascon J, Alonso-Padilla J. How effective are Rapid diagnostic tests for Chagas disease?. Exp Rev Anti-Infective Ther. 2021;19(12):1489–1494. doi: 10.1080/14787210.2021.1873130
  • Verani JR, Seitz A, Gilman RH, et al. Geographic variation in the sensitivity of recombinant antigen-based Rapid tests for chronic Trypanosoma cruzi infection. Am J Trop Med Hyg. 2009;80:410–415. doi: 10.4269/AJTMH.2009.80.410
  • Castro-Sesquen YE, Saldaña A, Patino Nava D, et al. Evaluation of 2 lateral flow Rapid tests in the diagnosis of Chagas disease in the Washington Metropolitan Area. Open Forum Infect Dis. 2021;8: doi: 10.1093/OFID/OFAB096
  • Truyens C, Dumonteil E, Alger J, et al. Geographic variations in test reactivity for the serological diagnosis of Trypanosoma cruzi infection. J Clin Microbiol. 2021;59. doi: 10.1128/JCM.01062-21
  • Abras A, Gállego M, Llovet T, et al. Serological diagnosis of chronic Chagas disease: is it time for a change? J Clin Microbiol. 2016;54:1566–1572. doi: 10.1128/JCM.00142-16
  • Avila HA, Pereira JB, Thiemann O, et al. Detection of Trypanosoma cruzi in blood specimens of chronic chagasic patients by polymerase chain reaction amplification of kinetoplast minicircle DNA: comparison with serology and Xenodiagnosis. J Clin Microbiol. 1993;31:2421. doi: 10.1128/JCM.31.9.2421-2426.1993
  • Britto C, Cardoso MA, Morel CM, et al. Trypanosoma cruzi: parasite detection and strain discrimination in chronic chagasic patients from northeastern Brazil using PCR amplification of kinetoplast DNA and nonradioactive hybridization. Exp Parasitol. 1995;81:462–471. doi: 10.1006/EXPR.1995.1139
  • Moser DR, Kirchhoff LV, Donelson JE. Detection of Trypanosoma cruzi by DNA amplification using the polymerase chain reaction. J Clin Microbiol. 1989;27:1477. doi: 10.1128/JCM.27.7.1477-1482.1989
  • Duffy T, Cura CI, Ramirez JC, et al. Analytical performance of a multiplex real-time PCR assay using TaqMan probes for quantification of Trypanosoma cruzi satellite DNA in blood samples. PLoS Negl Trop Dis. 2013;7(1):e2000 doi: 10.1371/journal.pntd.0002000
  • Ramírez JC, Cura CI, Da Cruz Moreira O, et al. Analytical validation of quantitative real-time PCR methods for quantification of Trypanosoma cruzi DNA in blood samples from Chagas disease patients. J Mol Diagn. 2015;17:605–615. doi: 10.1016/J.JMOLDX.2015.04.010
  • Schijman AG, Bisio M, Orellana L, et al. International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients. PLoS Negl Trop Dis. 2011;5(1):e931.
  • Porrás AI, Yadon ZE, Altcheh J, et al. Target product profile (TPP) for Chagas disease point-of-care diagnosis and assessment of response to treatment. PLoS Negl Trop Dis. 2015;9(6):e0003697. doi: 10.1371/JOURNAL.PNTD.0003697
  • Cura CI, Ramírez JC, Rodríguez M, et al. Comparative study and analytical verification of PCR methods for the diagnosis of congenital Chagas disease. J Mol Diagn. 2017;19:673–681. doi: 10.1016/j.jmoldx.2017.05.010
  • Basile L, Ciruela P, Requena-Méndez A, et al. Epidemiology of congenital Chagas disease 6 years after implementation of a public Health surveillance System, Catalonia, 2010 to 2015. Eurosurveillance. 2019;24:1. doi: 10.2807/1560-7917.ES.2019.24.26.19-00011
  • Suárez C, Nolder D, García-Mingo A, et al. Diagnosis and clinical management of Chagas disease: an increasing challenge in non-endemic areas. Res Rep Trop Med. 2022;13:25–40. doi: 10.2147/RRTM.S278135
  • Benatar AF, Danesi E, Besuschio SA, et al. Prospective multicenter Evaluation of real time PCR kit prototype for early diagnosis of congenital Chagas disease. EBioMedicine. 2021;69:103450. doi: 10.1016/J.EBIOM.2021.103450
  • PAHO EMTCT Plus. Framework for elimination of mother-to-child transmission of HIV, syphilis, hepatitis B, and Chagas. Washington DC: Pan American Health Organization; 2017.
  • Alonso-Padilla J, Gallego M, Schijman AG, et al. Molecular diagnostics for Chagas disease: up to date and novel methodologies. Expert Rev Mol Diagn. 2017;17(7):699–710. doi: 10.1080/14737159.2017.1338566
  • Srivastava P, Prasad D. Isothermal nucleic acid amplification and its uses in modern diagnostic technologies. 3 Biotech. 2023;13:200. doi: 10.1007/S13205-023-03628-6
  • Jimenez-Coello M, Shelite T, Castellanos-Gonzalez A, et al. Efficacy of recombinase polymerase amplification to diagnose Trypanosoma cruzi infection in dogs with cardiac alterations from an endemic area of Mexico. Vector-Borne Zoonotic Dis. 2018;18:417–423. doi: 10.1089/VBZ.2017.2258
  • Besuschio SA, Picado A, Muñoz-Calderón A, et al. Trypanosoma cruzi loop-mediated isothermal amplification (Trypanosoma cruzi Loopamp) kit for detection of congenital, acute and Chagas disease reactivation. PLoS Negl Trop Dis. 2020;14:1–17. doi: 10.1371/JOURNAL.PNTD.0008402
  • Bisio M, Rivero R, Gonzalez N·, et al. Diagnostic accuracy of two molecular tools for diagnosis of congenital Chagas disease. Mol Diagn Ther. 2021;25:791–801. doi: 10.1007/s40291-021-00553-3
  • Muñoz-Calderón AA, Besuschio SA, Wong S, et al. Loop-mediated isothermal amplification of Trypanosoma cruzi DNA for point-of-care follow-up of anti-parasitic treatment of Chagas disease. Microorganisms. 2022;10(5):909.
  • Longhi SA, García Casares LJ, Muñoz-Calderón AA, et al. Combination of ultra-Rapid DNA purification (PURE) and loop-mediated isothermal amplification (LAMP) for Rapid detection of Trypanosoma cruzi DNA in dried blood spots. PLoS Negl Trop Dis. 2023;17:e0011290. doi: 10.1371/JOURNAL.PNTD.0011290
  • Ahmed HA, MacLeod ET, Hide G, et al. The best practice for preparation of samples from FTA®cards for diagnosis of blood borne infections using African trypanosomes as a model System. Parasites Vectors. 2011;4(1):1–7. doi: 10.1186/1756-3305-4-68
  • Oriero EC, Okebe J, Jacobs J, et al. Diagnostic performance of a novel loop-mediated isothermal amplification (LAMP) assay targeting the apicoplast genome for malaria diagnosis in a field setting in Sub-Saharan Africa. Malar J. 2015;14(1):1–6. doi: 10.1186/s12936-015-0926-6
  • Wehrendt DP, Alonso-Padilla J, Liu B, et al. Development and Evaluation of a three-dimensional printer–based DNA extraction method coupled to loop mediated isothermal amplification for point-of-care diagnosis of congenital Chagas disease in endemic regions. J Mol Diagn. 2021;23:389–398. doi: 10.1016/j.jmoldx.2020.12.007
  • Peverengo LM, Rodeles LM, Maldonado C, et al. Congenital Chagas disease: development and assessment of a specific IgM capture-based assay for diagnosis of transmission. Acta Trop. 2021;213:105738. doi: 10.1016/J.ACTATROPICA.2020.105738
  • Messenger LA, Gilman RH, Verastegui M, et al. Toward improving early diagnosis of congenital Chagas disease in an endemic setting. Clin Infect Dis. 2017;65:268. doi: 10.1093/CID/CIX277
  • Rodriguez P, Truyens C, Alonso-Vega C, et al. Dosificación de Anticuerpos IgM e IgA Anti-Trypanosoma cruzi En Sangre de Recién Nacidos de Madres Con Serología Positiva Para Chagas. Rev Soc Bras Med Trop. 2005;2005:62–64.
  • WHO. Anti-Trypanosoma Cruzi Assays: Operational Characteristics, Report 1; Geneva. 2010 [cited 2023 Jul 19]. Available from: https://iris.who.int/handle/10665/75844?locale-attribute=ru&mode=full
  • Flores-Chávez M, de Fuentes I, Gárate T, et al. Diagnóstico de Laboratorio de La Enfermedad de Chagas Importada. Enferm Infec Microbiol Clin. 2007;25:29–37. doi: 10.1157/13111835
  • Riera C, Verges M, Iniesta L, et al. Identification of a Western blot pattern for the specific diagnosis of Trypanosoma cruzi infection in human sera. Am J Trop Med Hyg. 2012;86:412. doi: 10.4269/ajtmh.2012.11-0111
  • Meira WSF, Galvão LMC, Gontijo ED, et al. Trypanosoma cruzi Recombinant Complement Regulatory Protein: A Novel Antigen for Use in an Enzyme-Linked Immunosorbent Assay for Diagnosis of Chagas’ Disease. J Clin Microbiol. 2002;40:3735. doi: 10.1128/JCM.40.10.3735-3740.2002
  • Caicedo Díaz RA, Forsyth C, Bernal OA, et al. Comparative Evaluation of immunoassays to improve access to diagnosis for Chagas disease in Colombia. Inter J Infect Dis. 2019;87:100–108. doi: 10.1016/J.IJID.2019.07.022
  • Araújo AB, Berne MEA. Conventional serological performance in diagnosis of Chagas’ disease in Southern Brazil. Braz J Infect Dis. 2013;17:174–178. doi: 10.1016/J.BJID.2012.10.013
  • Santos FLN, De Souza WV, Da Silva Barros M, et al. Chronic Chagas disease diagnosis: a Comparative performance of commercial enzyme immunoassay tests. Am J Trop Med Hyg. 2016;94:1034. doi: 10.4269/AJTMH.15-0820
  • Leiby DA, Wendel S, Takaoka DT, et al. Serologic testing for Trypanosoma cruzi: comparison of radioimmunoprecipitation assay with commercially available indirect immunofluorescence assay, indirect hemagglutination assay, and enzyme-linked immunosorbent assay kits. J Clin Microbiol. 2000;38:639. doi: 10.1128/JCM.38.2.639-642.2000
  • Murcia L, Carrilero B, Saura D, et al. Diagnóstico y Tratamiento de La Enfermedad de Chagas. Enferm Infec Microbiol Clin. 2013;31:26–34. doi: 10.1016/S0213-005X(13)70111-3
  • Vircell Microbiologists CHAGAS IFA. [cited 2023 Jul 19]. Available form: https://www.vircell.com/producto/chagas-ifa/
  • Kelly EA, Bulman CA, Gunderson EL, et al. Comparative performance of latest-generation and FDA-Cleared serology tests for the diagnosis of Chagas disease. J Clin Microbiol. 2021;59: doi: 10.1128/JCM.00158-21
  • Luquetti AO, Espinoza B, Martínez I, et al. Performance levels of four Latin American laboratories for the serodiagnosis of Chagas disease in Mexican sera samples. Mem Inst Oswaldo Cruz. 2009;104:797–800. doi: 10.1590/S0074-02762009000500023
  • Guzmán-Gómez D, López-Monteon A, De La Soledad Lagunes-Castro M, et al. Highly Discordant Serology against Trypanosoma cruzi in Central Veracruz, Mexico: Role of the Antigen Used for Diagnostic. Parasites Vectors. 2015;8: doi: 10.1186/S13071-015-1072-2
  • Cinquanta L, Fontana DE, Bizzaro N. Chemiluminescent Immunoassay Technology: What Does It Change in Autoantibody Detection? Auto-Immun Highlights. 2017;8. doi: 10.1007/S13317-017-0097-2
  • Pérez-Ayala A, Fradejas I, Rebollo L, et al. Usefulness of the ARCHITECT Chagas® assay as a single test for the diagnosis of chronic Chagas disease. Trop Med Int Health. 2018;23:634–640. doi: 10.1111/TMI.13063
  • Flores-Chávez M, Cruz I, Rodríguez M, et al. Comparison of conventional and non-conventional serological tests for the diagnosis of imported Chagas disease in Spain. Enferm Infec Microbiol Clin. 2010;28:284–293. doi: 10.1016/j.eimc.2009.07.005
  • Flores-Chavez M, Cruz I, Nieto J, et al. Sensitivity and specificity of an Operon immunochromatographic test in serum and whole-blood samples for the diagnosis of Trypanosoma cruzi infection in Spain, an area of nonendemicity. Clin Vaccine Immunol. 2012;19:1353. doi: 10.1128/CVI.00227-12
  • Navarro M, Perez-Ayala A, Guionnet A, et al. Targeted screening and health education for Chagas disease tailored to at-risk migrants in Spain, 2007 to 2010. Eurosurveillance. 2011;16:19973. doi: 10.2807/ESE.16.38.19973-EN/CITE/PLAINTEXT
  • Sánchez-Camargo CL, Albajar-Viñas P, Wilkins PP, et al. Comparative Evaluation of 11 Commercialized Rapid Diagnostic Tests for Detecting Trypanosoma cruzi Antibodies in Serum Banks in Areas of Endemicity and Nonendemicity. J Clin Microbiol. 2014;52(7):2506–2512. doi: 10.1128/JCM.00144-14
  • Shah V, Ferrufino L, Gilman RH, et al. Field Evaluation of the InBios Chagas detect plus Rapid test in serum and whole-blood specimens in Bolivia. Clin Vaccine Immunol. 2014;21(12):1645–1649. doi: 10.1128/CVI.00609-14
  • Whitman JD, Bulman CA, Gunderson EL, et al. Chagas disease serological test performance in U.S. Blood donor specimens. J Clin Microbiol. 2019;57: doi: 10.1128/JCM.01217-19
  • FIND. Panorama Tecnológico de Los Productos de Diagnóstico Para La Enfermedad de Chagas; 2022 [cited 2023 Jul 18th]. Available from: https://www.finddx.org/wp-content/uploads/2023/04/20221221_rep_lsc_technical_chagas_FV_ES.pdf
  • Barfield CA, Barney RS, Crudder CH, et al. A highly sensitive Rapid diagnostic test for Chagas disease that utilizes a recombinant Trypanosoma Cruzi Antigen. IEEE Trans Biomed Eng. 2011;58:814. doi: 10.1109/TBME.2010.2087334
  • Chappuis F, Mauris A, Holst M, et al. Validation of a Rapid immunochromatographic assay for diagnosis of Trypanosoma cruzi infection among Latin-American migrants in Geneva, Switzerland. J Clin Microbiol. 2010;48:2948. doi: 10.1128/JCM.00774-10
  • Chippaux JP, Santalla JA, Postigo JR, et al. Sensitivity and specificity of Chagas stat-pak test in Bolivia. Trop Med Int Health. 2009;14:732–735. doi: 10.1111/J.1365-3156.2009.02288.X
  • Luquetti AO, Ponce C, Ponce E, et al. Chagas’ disease diagnosis: a multicentric Evaluation of Chagas stat-pak, a Rapid immunochromatographic assay with recombinant proteins of Trypanosoma cruzi. Diagn Microbiol Infect Dis. 2003;46(4):265–271. doi: 10.1016/S0732-8893(03)00051-8
  • Ponce C, Ponce E, Vinelli E, et al. Validation of a Rapid and reliable test for diagnosis of Chagas’ disease by detection of Trypanosoma cruzi-specific antibodies in blood of donors and patients in Central America. J Clin Microbiol. 2005;43:5065. doi: 10.1128/JCM.43.10.5065-5068.2005
  • Roddy P, Goiri J, Flevaud L, et al. Field Evaluation of a Rapid immunochromatographic assay for detection of Trypanosoma cruzi infection by use of whole blood. J Clin Microbiol. 2008;46:2022. doi: 10.1128/JCM.02303-07
  • Iturra JAD, Leony LM, Medeiros FAC, et al. A multicenter Comparative study of the performance of four Rapid immunochromatographic tests for the detection of anti-Trypanosoma cruzi antibodies in Brazil. Front Med. 2023;10:1031455. doi: 10.3389/FMED.2023.1031455/FULL
  • Ji MJ, Noh JS, Cho BK, et al. Evaluation of SD BIOLINE Chagas Ab Rapid Kit. Korean J Lab Med. 2009;29:48–52. doi: 10.3343/KJLM.2009.29.1.48
  • Martinez N, Gonzalez Arra M, Delgado D, et al. Evaluation of a Rapid test for serological diagnosis of Chagas disease, in Mendoza, Argentina. J Microbiol Exp. 2021;9:39–40. doi: 10.15406/JMEN.2021.09.00321
  • Mendicino D, Stafuza M, Colussi C, et al. Diagnostic reliability of an immunochromatographic test for Chagas screening at a primary Health care centre in a rural endemic. Mem Inst Oswaldo Cruz. 2014;109:984. doi: 10.1590/0074-0276140153
  • Acosta M Desarrollo y Evaluación de Una Prueba Inmunocromatográfica Para El Diagnóstico de La Infección Con Trypanosoma cruzi/Development and Evaluation of an Immunochromatographic for the Diagnosis of Infection with T. cruzi, Universidad Nacional de Asunción: Asunción. 2013 [cited 2023 Jul 18th]. Ava: https://www.conacyt.gov.py/sites/default/files/TES-BN-012.pdf
  • Velásquez-Ortiz N, Herrera G, Hernández C, et al. Discrete typing units of Trypanosoma Cruzi: geographical and biological distribution in the Americas. Sci Data. 2022;9(1):1–8. doi: 10.1038/s41597-022-01452-w
  • Ortega-Arroyo A, Flores-Chavez MD, Puente-Alcaraz J. Combined use of two Rapid tests for the conclusive diagnosis of Chagas disease: a systematic scoping review. BMJ Open. 2021;11(10):e047825. doi: 10.1136/BMJOPEN-2020-047825
  • Shanmugasundram A, Starns D, Böhme U, et al. TriTrypDB: an integrated functional genomics resource for kinetoplastida. PLoS Negl Trop Dis. 2023;17:e0011058. doi: 10.1371/JOURNAL.PNTD.0011058
  • Michel-Todó L, Reche PA, Bigey P, et al. In silico design of an epitope-based Vaccine ensemble for Chagas disease. Front Immunol. 2019;10: doi: 10.3389/FIMMU.2019.02698/FULL
  • Zingales B, Bartholomeu DC. Trypanosoma cruzi genetic diversity: impact on transmission cycles and Chagas disease. Mem Inst Oswaldo Cruz. 2022;117:e210193. doi: 10.1590/0074-02760210193
  • Ricci AD, Bracco L, Salas-Sarduy E, et al. The Trypanosoma cruzi antigen and Epitope Atlas: antibody specificities in Chagas disease patients across the Americas. Nat Commun. 2023;14:1–18. doi: 10.1038/s41467-023-37522-9
  • Alonso-Padilla J, Cortés-Serra N, Pinazo MJ, et al. Strategies to enhance access to diagnosis and treatment for Chagas disease patients in Latin America. Expert Rev Anti Infect Ther. 2019;17:145–157. doi: 10.1080/14787210.2019.1577731
  • Alarcón De Noya B, Díaz-Bello Z, Colmenares C, et al. Update on Oral Chagas Disease Outbreaks in Venezuela: Epidemiological, Clinical and Diagnostic Approaches. Mem Inst Oswaldo Cruz Rio de Janeiro. 2015;110:377–386. doi: 10.1590/0074-02760140285
  • Laynez-Roldán P, Losada-Galván I, Posada E, et al. Characterization of Latin American migrants at risk for Trypanosoma cruzi infection in a non-endemic setting. Insights into initial evaluation of cardiac and digestive involvement infection in a non-endemic setting. Insights into initial evaluation of cardiac and digestive involvement. PLoS Negl Trop Dis. 2023;17:e0011330. doi: 10.1371/JOURNAL.PNTD.0011330
  • Generalitat de Catalunya A Protocol For Screening, Diagnosis And Treatment Of Chagas Disease In Pregnant Latin American Women, Their Newborns And Other Children. 2018 [cited 2023 Jul 19]. Available form: https://scientiasalut.gencat.cat/bitstream/handle/11351/1173/protocol_cribratge_diagnostic_malaltia_chagas_embarassades_2010_ang.pdf?sequence=8&isAllowed=y
  • Muñoz-Vilches M, Domínguez-Castellano A, Guerra-Martín M, et al. Cribado de Chagas En Embarazo y Neonato En Andalucía (España). An Sist Sanit Navar. 2019;42:281–290. doi: 10.23938/ASSN.0746
  • Xunta de Galicia Protocolo de Cribado Da Enfermidade de Chagas En Mulleres Embarazadas. 2014 [cited 2023 Jul 19th]. Available from: https://www.sergas.es/Asistencia-sanitaria/Documents/650/Protocolo%20de%20cribado%20da%20enfermidade%20de%20Chagas%20en%20mulleres%20embarazadas.pdf
  • Basile L, Oliveira I, Ciruela P, et al. The Current screening programme for congenital transmission of Chagas disease in Catalonia, Spain. Eurosurveillance. 2011;16(38). doi: 10.2807/ese.16.38.19972-en
  • Zelman BW, Baral R, Zarlinda I, et al. Costs and cost-effectiveness of malaria reactive case detection using loop-mediated isothermal amplification compared to microscopy in the low transmission setting of Aceh Province, Indonesia. Malar J. 2018;17(1):1–12 doi: 10.1186/s12936-018-2361-y
  • Donkeng-Donfack VF, Tchatchueng-Mbougua JB, Abanda NN, et al. A cost–benefit algorithm for Rapid diagnosis of tuberculosis and rifampicin resistance detection during mass screening campaigns. BMC Infect Dis. 2022;22(1):1–11 doi: 10.1186/s12879-022-07157-0
  • Moure Z, Angheben A, Molina I, et al. Serodiscordance in chronic Chagas disease diagnosis: a real problem in non-endemic countries. Clin Microbiol Infect. 2016;22:788–792. doi: 10.1016/J.CMI.2016.06.001
  • Reithinger R, Grijalva MJ, Chiriboga RF, et al. Rapid detection of Trypanosoma cruzi in human serum by use of an immunochromatographic dipstick test. J Clin Microbiol. 2010;48:3003. doi: 10.1128/JCM.02474-09
  • Carlier Y, Altcheh J, Angheben A, et al. Congenital Chagas disease: updated recommendations for prevention, diagnosis, treatment, and follow-up of newborns and siblings, girls, women of childbearing age, and pregnant women. PLoS Negl Trop Dis. 2019;13(10):e0007694. doi: 10.1371/JOURNAL.PNTD.0007694
  • Land KJ, Boeras DI, Chen XS, et al. REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes. Nat Microbiol. 2019;4:46. doi: 10.1038/S41564-018-0295-3
  • Mendes FDSNS, Perez-Molina JA, Angheben A, et al. Critical analysis of Chagas disease treatment in different countries. Mem Inst Oswaldo Cruz. 2022;117: doi: 10.1590/0074-02760210034
  • Basile L, Jansà JM, Carlier Y, et al. Chagas disease in European countries: the challenge of a surveillance System. Eurosurveillance. 2011;16(37). doi: 10.2807/ese.16.37.19968-en

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.